Skip to main content

D. E. Shaw & Co., Inc.

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1009207 New York, NY

Position in LGND

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$17,863,826
+$2,205,676 QoQ
Shares Held
56,515
-27.9% QoQ
Ownership
0.283%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#63
of 415 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Derivatives in LGND

reported options exposure · as of Jun 30, 2026
CallValue
$2,591,938
CallShares
8,200
PutValue
$885,052
PutShares
2,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,139,216,221 across 217 Biotechnology names. LGND ranks #55 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LGND

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,591,938 8,200
2026-06-30 $17,863,826 56,515
2026-06-30 $885,052 2,800
2026-03-31 $439,230 2,200
2026-03-31 $15,658,150 78,428
2026-03-31 $1,317,690 6,600
2025-12-31 $1,436,932 7,600
2025-12-31 $6,910,697 36,551
2025-09-30 $3,102,429 17,514
2025-09-30 $283,424 1,600
2025-06-30 $812,925 7,151
2024-06-30 $2,169,105 25,743
2024-03-31 $4,575,475 62,592
2023-12-31 $6,278,460 87,909
2023-09-30 $6,334,802 105,721
2023-06-30 $3,704,065 51,374
2023-03-31 $3,629,229 49,337
2022-12-31 $3,426,906 51,301
2021-06-30 $1,311,900 10,000
2021-03-31 $1,524,499 10,000
2021-03-31 $972,173 6,377
2020-12-31 $3,310,689 33,290
2020-09-30 $7,395,019 77,581
2020-06-30 $3,243,649 29,000
2020-06-30 $19,061,805 170,423
2020-03-31 $12,057,400 165,806
2020-03-31 $2,108,878 29,000